Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family.

Autor: Mahaffey CL; Jackson Laboratory, Bar Harbor, Maine 04609, USA., Bayleran JK, Yeh GY, Lee TC, Page DC, Simpson EM

Publikováno v: Genomics [Genomics] 1997 Apr 01; Vol. 41 (1), pp. 123-7.

Frequencies of cystic fibrosis mutations in the Maine population: high proportion of unknown alleles in individuals of French-Canadian ancestry.

Autor: Bayleran JK; Genetics Program, Eastern Maine Medical Center, Bangor 04401, USA. janetb@jax.org, Yan H, Hopper CA, Simpson EM

Publikováno v: Human genetics [Hum Genet] 1996 Aug; Vol. 98 (2), pp. 207-9.

Structural insights into the HNF4 biology.

Autor: Beinsteiner, Brice, Billas, Isabelle M. L., Moras, Dino

Publikováno v: Frontiers in Endocrinology; 2023, p1-15, 15p

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Autor: Patel JN; Department of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, Charlotte, NC, USA. jai.patel@atriumhealth.org., Jiang C; Alliance Statistics and Data Management Center, Duke University, Durham, NC, USA., Owzar K; Alliance Statistics and Data Management Center, Duke University, Durham, NC, USA.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Wang J; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA., Mulkey FA; Alliance Statistics and Data Management Center, Duke University, Durham, NC, USA., Kelly WK; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Halabi S; Alliance Statistics and Data Management Center, Duke University, Durham, NC, USA.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Furukawa Y; Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Lassiter C; University of Maryland School of Nursing (Miltenyi Biotech at time of publication), Baltimore, MD, USA., Dorsey SG; University of Maryland School of Nursing (Miltenyi Biotech at time of publication), Baltimore, MD, USA., Friedman PN; Department of Pharmacology and Center for Pharmacogenomics, Northwestern University, Evanston, IL, USA., Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Carducci MA; Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Kelley MJ; Durham VA Medical Center/Duke University Medical Center, Durham, NC, USA., Nakamura Y; Center for Personalized Therapeutics, University of Chicago (Japanese Foundation for Cancer Research, Ariake, Tokyo at time of publication), Chicago, IL, USA., Kubo M; Riken Center for Integrative Medical Sciences (Haradoi Hospital, Fukuoka, Japan at time of publication), Kanagawa, Japan., Ratain MJ; Center for Personalized Therapeutics, University of Chicago (Japanese Foundation for Cancer Research, Ariake, Tokyo at time of publication), Chicago, IL, USA., Morris MJ; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McLeod HL; Utah Tech University, St. George, UT, USA.

Publikováno v: The pharmacogenomics journal [Pharmacogenomics J] 2024 Mar 04; Vol. 24 (2), pp. 6. Date of Electronic Publication: 2024 Mar 04.